-
Mashup Score: 0
AbstractBackgroundThe relative efficacy and safety of allopurinol and febuxostat when used according to current guidelines for the treatment of hyperuricemia are unknown. This double-blind noninfer…
Source: evidence.nejm.orgCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0How to Publish a Manuscript - 2 year(s) ago
Poor Nana
Source: YouTubeCategories: Latest Headlines, RheumatologyTweet-
For all my academic colleagues this is chillingly accurate & very funny from @DGlaucomflecken “How to Publish a Manuscript” https://t.co/vGL5zvPRAi H/T @JaneBursle
-
-
Mashup Score: 0A genome-wide screen for variants influencing certolizumab pegol response in a moderate to severe rheumatoid arthritis population - 2 year(s) ago
Certolizumab pegol (CZP) is a PEGylated Fc-free tumor necrosis factor (TNF) inhibitor antibody approved for use in the treatment of rheumatoid arthritis (RA), Crohn’s disease, psoriatic arthritis, axial spondyloarthritis and psoriasis. In a clinical trial of patients with severe RA, CZP improved disease symptoms in approximately half of patients. However, variability in CZP efficacy remains a…
Source: journals.plos.orgCategories: Latest Headlines, RheumatologyTweet-
These are the types of studies that will really start to advance therapeutics & personalised medicine in rheumatology => A genome-wide screen for variants influencing certolizumab pegol response in rheumatoid arthritis https://t.co/9ZtpVkYKcI
-
-
Mashup Score: 0
Ruxolitinib 5 mg twice per day showed no benefit in the overall study population. A larger sample is required to determine the clinical importance of trends for increased efficacy in patient subgroups.
Source: The Lancet RheumatologyCategories: Latest Headlines, RheumatologyTweet-
Negative JAK-1/2 trial (ruxolitinib) in COVID-19 https://t.co/RzV5TsP3IW @TheLancetRheum
-
-
Mashup Score: 0
Objective While COVID-19 vaccination prevents severe infections, poor immunogenicity in immunocompromised people threatens vaccine effectiveness. We analysed the clinical characteristics of patients with rheumatic disease who developed breakthrough COVID-19 after vaccination against SARS-CoV-2. Methods We included people partially or fully vaccinated against SARS-CoV-2 who developed COVID-19…
Source: RMD OpenCategories: Latest Headlines, RheumatologyTweet-
Breakthrough infections in vaccinated rheumatic disease patients, from @rheum_covid @rheum_cat https://t.co/0hzfn874IX
-
-
Mashup Score: 0
Without question, basic immunology is at the foundation of rheumatology as a discipline. Indeed, for many rheumatologists, it was the intricacies of the immune system that attracted us into the field. With each passing year, extraordinary advances in scientific methods begat tremendous gains in our understanding of the immune system. Excitingly, we may be entering a new era, driven by results in…
Source: rheumnow.comCategories: Latest Headlines, RheumatologyTweet-
Combining biologics is super exciting, thanks Artie Kavanaugh and @RheumNow for highlighting, I await further trail data 😀 https://t.co/aZhMo2XiFR
-
-
Mashup Score: 2Ten Years of Choosing Wisely to Reduce Low-Value Care | NEJM - 2 year(s) ago
Perspective from The New England Journal of Medicine — Ten Years of Choosing Wisely to Reduce Low-Value Care
Source: New England Journal of MedicineCategories: Latest Headlines, RheumatologyTweet-
Very good article in the challenges and realities of Choosing Wisely and how we should reevaluate the program: “Ten Years of Choosing Wisely to Reduce Low-Value Care” @NEJM @drdavidliew https://t.co/GQeb6sUwlj
-
-
Mashup Score: 1
The use of obscene or taboo language – or swearing, as it’s more commonly known – is often seen as a sign that the speaker lacks vocabulary, cannot express themselves in a less offensive way, or even lacks intelligence.
Source: ScienceAlertCategories: Latest Headlines, RheumatologyTweet-
Swearing Is Actually a Sign of More Intelligence - Not Less - Say Scientists @alhkim 😜 https://t.co/55bEBHGgJg
-
-
Mashup Score: 0Is hybrid work the worst of both worlds? - 2 year(s) ago
Evidence is piling up that it might be
Source: The EconomistCategories: Latest Headlines, RheumatologyTweet-
For those with @TheEconomist access, this is an interesting piece => Hybrid work, the worst of both worlds? https://t.co/rztQOmMZIG from https://t.co/rztQOmMZIG
-
-
Mashup Score: 1Menopausal arthralgia: Fact or fiction - 2 year(s) ago
Arthralgia is experienced by more then half of the women around the time of menopause. The causes of joint pain in postmenopausal women can be difficult to determine as the period of menopause coincides with rising incidence of chronic rheumatic conditions such as osteoarthritis. Nevertheless, prevalence of arthralgia does appear to increase in women with menopausal transition and is thought to…
Source: MaturitasCategories: Latest Headlines, RheumatologyTweet-
What are people's view on menopausal arthralgia? Have had a number of people come in and report arthralgia and say, "it's probably all because I am menopausal" https://t.co/0I3VB7UhI5
-
And here it is in all its glory, what a beautiful study => Comparative Effectiveness of Allopurinol and Febuxostat in Gout Management | NEJM Evidence @Tuhina_Neogi https://t.co/VpMpvrBDO4